Evaluation of PIMA™® Point of Care Technology for CD4 T Cell Enumeration in Kenya

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Mwau, Matilu ^a   Adungo, Ferdinard ^a   Kadima, Silvia ^a   Njagi, Ephantus ^c   Kirwaye, Carolyne ^a   Abubakr, Najma Salim ^a   Okubi, Lucy Atsieno ^a   Waihenya, Mary ^a   Lusike, Judi ^b   Hungu, Jackson ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b CLINTON HEALTH ACCESS INITIATIVE   (United States)

^c Deloitte Consulting LLC   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; CYTOMETER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERMETHOD COMPARISON; KENYA; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PRESCHOOL CHILD; REPRODUCIBILITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KENYA; LINEAR MODELS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; YOUNG ADULT;

EID: 84879352255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067612     Document Type: Article

References (26)

1. CDC (1997) 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention. 1057-5987 (Print) 1057-5987 (Linking). 1-29 p.
2. Mandy FF, Nicholson JK, McDougal JS, (2003) Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 52: 1-13.
3. When To Start C, Sterne JA, May M, Costagliola D, de Wolf F, et al. (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352-1363.
4. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, et al. (2005) Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 366: 378-384.
5. Chene G, Sterne JA, May M, Costagliola D, Ledergerber B, et al. (2003) Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 362: 679-686.
6. Rouet F, Inwoley A, Ekouevi DK, Viho I, Becquet R, et al. (2006) CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings. J Trop Pediatr 52: 346-354.
7. Marinucci F, Medina-Moreno S, Paterniti AD, Wattleworth M, Redfield RR, (2011) Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries. Cytometry A 79: 368-374.
8. Peter T, Badrichani A, Wu E, Freeman R, Ncube B, et al. (2008) Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom 74Suppl 1: S123-130.
9. Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, et al. (2011) Viewpoint: Why do we need a point-of-care CD4 test for low-income countries? Trop Med Int Health 16: 37-41.
10. Fox J, Dunn H, O'Shea S, (2011) Low rates of p24 antigen detection using a fourth-generation point of care HIV test. Sex Transm Infect 87: 178-179.
11. Usdin M, Guillerm M, Calmy A, (2010) Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J Infect Dis 201Suppl 1: S73-77.
12. Peeling RW, Mabey D, (2010) Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 16: 1062-1069.
13. Bissonnette L, Bergeron MG, (2010) Diagnosing infections-current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect 16: 1044-1053.
14. Prince HE, Lesar WJ, (1989) Simultaneous determination of absolute total lymphocyte and CD4+ lymphocyte levels in peripheral blood by flow cytometry. Am J Clin Pathol 92: 206-209.
15. Herbert S, Edwards S, Carrick G, Copas A, Sandford C,et al. (2012) Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Sex Transm Infect.
16. Larson B, Schnippel K, Ndibongo B, Long L, Fox MP, et al. (2012) How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa. PLoS One 7: e35444.
17. Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, et al. (2011) Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4. J Acquir Immune Defic Syndr 58: e103-111.
18. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, et al. (2010) Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 55: 1-7.
19. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, et al. (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378: 1572-1579.
20. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
21. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, et al. (2011) Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr 58: 141-147.
22. Manasa J, Musabaike H, Masimirembwa C, Burke E, Luthy R, et al. (2007) Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccine Immunol 14: 293-298.
23. Thakar M, Mahajan B, Shaikh N, Bagwan S, Sane S, et al. (2012) Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India. AIDS Res Ther 9: 26.
24. Herbert S, Edwards S, Carrick G, Copas A, Sandford C, et al. (2012) Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Sex Transm Infect 88: 413-417.
25. Glencross DK, Coetzee LM, Faal M, Masango M, Stevens WS, et al. (2012) Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc 15: 3.
26. Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, et al. (2011) Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS 25: 807-812.